Benlysta benchmarks: Progress of the GSK-HGSI lupus treatment so far
Links shared publicly online about this topic.
- 77total visits
Benlysta benchmarks: Progress of the GSK-HGSI lupus treatment so far
New lupus drug Benlysta received FDA approval in March and has since reached several additional milestones. Read about the drug's progress so far.
View full resource at medcitynews.com
Most Recently Shared on August 12, 2011 at 5:30 pm By:
Benlysta benchmarks: Progress of the GSK-HGSI lupus treatment so far http://t.co/u4IubHV
Advertisement
